Is CI a strong buy?
The Cigna Group (CI) is widely viewed favorably by Wall Street analysts, with a consensus rating that leans toward a "Strong Buy." As of late July 2026, data indicates that approximately 35% of analysts covering the stock explicitly recommend it as a "Strong Buy," while a combined total of over 80% provide a "Buy" or "Strong Buy" rating. This optimistic outlook is supported by many research firms that have reiterated "Buy" or "Overweight" ratings despite various sector headwinds and preliminary outlook concerns voiced earlier in the year. The stock is frequently highlighted by institutional analysts for its fundamental strength and resilience in the healthcare and insurance sector. While analysts maintain varying price targets, the general institutional sentiment strongly favors CI, positioning it as one of the more highly regarded stocks in its industry segment among professional market observers.
Related FAQs
Cipher Mining (trading under the ticker CIFR) has experienced capital structure adjustments typical of high-growth digital infrastructure and bitcoin mining enterprises, but it has not implemented a traditional retail-oriented stock split of its c...
DaVita Inc. is one of the largest kidney care and dialysis service providers in the United States, operating hundreds of outpatient centers that treat patients with chronic kidney failure.
Executive compensation for Stephen M. Spray, serving as the President and Chief Executive Officer of Cincinnati Financial Corporation, reflects leadership in the property and casualty insurance sector.
Cigna (CI) is generally considered to be undervalued by many market analysts and valuation models when compared to the company's long-term earnings potential.
No, Cigna is not as large as UnitedHealthcare. UnitedHealthcare is the largest health insurance provider in the United States, maintaining a significant advantage in terms of scale, diversification, and overall profitability.
Yes, The Cigna Group is performing well financially. The company reported strong results for the first quarter of 2026, with total revenues of $68.5 billion, representing a 5% increase compared to the previous year.
The outlook for Cigna's stock in 2026 is generally positive, with many Wall Street analysts forecasting growth. As of late July 2026, the average price target set by analysts for Cigna Group shares is approximately $338.
Yes, Cigna announced a significant workforce reduction in early 2026. The company laid off approximately 2,000 employees, which represents just under 3% of its global workforce of about 73,500 people.
As of late July 2026, the analyst consensus for The Cigna Group (CI) stock is a "Buy.